NIMSAH

Serial Number 97253497
Registration 7868373
700

Registration Progress

Application Filed
Feb 4, 2022
Under Examination
Aug 1, 2023
Approved for Publication
Dec 13, 2022
Published for Opposition
Dec 13, 2022
Registered
Jul 15, 2025

Trademark Image

NIMSAH

Basic Information

Serial Number
97253497
Registration Number
7868373
Filing Date
February 4, 2022
Registration Date
July 15, 2025
Published for Opposition
December 13, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 15, 2025
Registration
Registered
Classes
005

Rights Holder

GRACE THERAPEUTICS U.S., INC.

03
Address
103 CARNEGIE CENTER, SUITE 300
PRINCETON, NJ 08540

Ownership History

Acasti Pharma US Inc.

Original Applicant
03
North Brunswick, NJ

Acasti Pharma US Inc.

Owner at Publication
03
Princeton, NJ

GRACE THERAPEUTICS U.S., INC.

New Owner After Publication #1
03
PRINCETON, NJ

GRACE THERAPEUTICS U.S., INC.

Original Registrant
03
PRINCETON, NJ

Legal Representation

Attorney
Allison Strickland Ricketts

USPTO Deadlines

Next Deadline
2029 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250715)
Due Date
July 15, 2031
Grace Period Ends
January 15, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

44 events
Date Code Type Description Documents
Jul 15, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 15, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 16, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 20, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 30, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 5, 2025 IUAF S USE AMENDMENT FILED Loading...
May 30, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 6, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 21, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 20, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 20, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 15, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 15, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 15, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 13, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 19, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 19, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 19, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 15, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 15, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 4, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 2, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 2, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 2, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 1, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 22, 2023 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
May 4, 2023 CHPB I POST PUBLICATION AMENDMENT - ENTERED Loading...
May 1, 2023 APET A ASSIGNED TO PETITION STAFF Loading...
Apr 11, 2023 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Jan 2, 2023 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Dec 13, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 13, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 23, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 7, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 7, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 7, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 7, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 7, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 4, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 9, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 8, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for treating subarachnoid hemorrhage administered by intravenous infusion and dispensed only in advanced medical care settings
First Use Anywhere: 20250200
First Use in Commerce: 20250200

Additional Information

Translation
The wording "NIMSAH" has no meaning in a foreign language.

Classification

International Classes
005